N@N

Osteotech (OSTE) Gains As Much As 1.41% After BUYINS.NET Report Predicted On August 30th The Stock Would Rally On Seasonal Stre

^{Published on 2010-09-29 09:08:50, Last Modified on 2010-12-22 18:55:38 - WOPRAI}
 

September 29, 2010 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on August 30th, 2010 stating that Osteotech (NASDAQ: OSTE) was expected to be higher due to seasonal strength in the stock. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?id=122311

The results of the prediction are the following:

Symbol 8/30/2010 Hi Since $Change % High 9/28/2010 $Change % Today

OSTE $6.39 $6.48 $0.09 1.41% $6.48 $0.09 1.41%

By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

Osteotech, Inc. (NASDAQ: OSTE) develops biologic products for orthopedic, spinal, trauma, neurosurgical, and oral/maxillofacial surgeons for use in various surgical procedures. The company operates in five segments: Demineralized Bone Matrix (DBM), Hybrid/Synthetic, Traditional Tissue, Spinal Allograft, and Client Services. The DBM segment markets Grafton DBM products, which are allograft bone tissue grafts processed from allograft bone tissues; and Xpanse bone inserts. The Hybrid/Synthetic segment offers biocomposite and synthetic material products, including the MagniFuse bone graft and Plexur biocomposites; and GraftCage spacers. The Traditional Tissue segment converts allograft bone tissue into mineralized weight-bearing and non-weight bearing tissue forms and soft tissue grafts. Its weight-bearing tissue forms include femoral cross sections, fibula wedges, and cortical struts; and the non-weight bearing tissue forms comprise cancellous and cortical chips. This segmenta�s soft tissue grafts are utilized primarily in sports medicine procedures. The Spinal Allograft segment provides Facetlinx, a patented spinal allograft product for use in facet fusion procedure applications. It also distributes Graftech bio-implant spacers and ramps that are used primarily in spinal fusion procedures. The Client Services segment processes allograft bone tissue for the clients. The company intends to introduce its first product stemming from its Human Collagen Technology Platform, the DuraTech BioRegeneration Matrix for use in the repair of dura mater during surgical procedures. It also plans to introduce additional human collagen-based tissue products that address patient needs, including rotator cuff repair, wound care, and abdominal wall reconstruction. It sells its products in the United States, Europe, Latin America, and Asia. Osteotech, Inc. was founded in 1986 and is based in Eatontown, New Jersey.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net